Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
OrbiMed Advisors’ $208 Million Acquisition of Neurelis
OrbiMed’s Financing Agreement with Poxel
OrbiMed was advised by LPA-CGR, BCLP, and Covington & Burling. Dechert LLP (Paris and New York) advised Poxel. OrbiMed announced it has entered into a non-dilutive...
OrbiMed’s $50 Million Financing
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
OrbiMed’s $4.3 Billion Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented OrbiMed on the transaction. OrbiMed announced it has raised more than $4.3 billion in commitments for its latest private investment...
OrbiMed’s $125 Million Debt Financing
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
OrbiMed’s $75 Million Debt Financing
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
OrbiMed Advisors and Deerfield’s $40 Million Follow-On Financing Agreement With Valneva
Bryan Cave Leighton Paisner (BCLP) has advised two U.S. healthcare investment funds, Orbimed Advisors and Deerfield Management Company. Valneva was advised in France by Hogan Lovells...
Orbimed’s $30 Million Investment into Lifecell International
IndusLaw advised Orbimed on the deal, while Lakshmikumaran & Sridharan advised LifeCell International. Orbimed announced its investment of Approx. $30 million in Lifecell International. LifeCell International Private...
Century Therapeutics’ $160-million Series C Financing
Brown Rudnick LLP advised lead investor Casdin Capital and a syndicate of new investors, while White & Case LLP advised Qatar Investment Authority on the deal....